 Jacob Lebin
Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Overdose | 6 | 2021 | 326 | 1.460 |
Why?
| | Substance Withdrawal Syndrome | 2 | 2023 | 175 | 1.360 |
Why?
| | Hydroxychloroquine | 2 | 2021 | 55 | 1.350 |
Why?
| | Naloxone | 3 | 2020 | 112 | 1.340 |
Why?
| | Analgesics, Non-Narcotic | 2 | 2021 | 122 | 1.340 |
Why?
| | Narcotic Antagonists | 3 | 2020 | 164 | 1.280 |
Why?
| | Alcoholism | 2 | 2023 | 764 | 1.010 |
Why?
| | Emergency Service, Hospital | 5 | 2025 | 1918 | 1.000 |
Why?
| | Crataegus | 2 | 2020 | 8 | 0.860 |
Why?
| | Chloroquine | 2 | 2021 | 51 | 0.840 |
Why?
| | Chemical and Drug Induced Liver Injury | 2 | 2021 | 132 | 0.840 |
Why?
| | Opiate Substitution Treatment | 1 | 2025 | 136 | 0.830 |
Why?
| | Syncope | 1 | 2023 | 51 | 0.820 |
Why?
| | Acetaminophen | 3 | 2021 | 248 | 0.810 |
Why?
| | Delirium | 1 | 2024 | 77 | 0.800 |
Why?
| | Analgesics, Opioid | 3 | 2019 | 919 | 0.780 |
Why?
| | Methylene Blue | 2 | 2021 | 23 | 0.770 |
Why?
| | Decision Support Systems, Clinical | 1 | 2025 | 206 | 0.750 |
Why?
| | Opioid-Related Disorders | 3 | 2025 | 484 | 0.730 |
Why?
| | Circulating MicroRNA | 1 | 2021 | 25 | 0.720 |
Why?
| | Buprenorphine | 1 | 2025 | 162 | 0.720 |
Why?
| | Hand Sanitizers | 1 | 2020 | 2 | 0.690 |
Why?
| | Seizures | 1 | 2023 | 402 | 0.660 |
Why?
| | Sodium Chloride | 1 | 2020 | 137 | 0.650 |
Why?
| | Dietary Supplements | 2 | 2020 | 532 | 0.630 |
Why?
| | Anesthetics, Dissociative | 1 | 2019 | 28 | 0.620 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 65 | 0.600 |
Why?
| | Oxymorphone | 1 | 2018 | 3 | 0.590 |
Why?
| | Drug Prescriptions | 1 | 2020 | 242 | 0.590 |
Why?
| | Prescription Drug Diversion | 1 | 2018 | 12 | 0.580 |
Why?
| | Ketamine | 1 | 2019 | 89 | 0.580 |
Why?
| | Narcotics | 1 | 2018 | 45 | 0.580 |
Why?
| | Oxycodone | 1 | 2018 | 43 | 0.570 |
Why?
| | Betacoronavirus | 1 | 2020 | 252 | 0.550 |
Why?
| | Teratoma | 1 | 2018 | 103 | 0.550 |
Why?
| | Benzodiazepines | 3 | 2023 | 138 | 0.520 |
Why?
| | Nitric Oxide | 1 | 2021 | 897 | 0.490 |
Why?
| | Pandemics | 2 | 2020 | 1500 | 0.480 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 342 | 0.480 |
Why?
| | Coronavirus Infections | 1 | 2020 | 336 | 0.470 |
Why?
| | MicroRNAs | 1 | 2021 | 677 | 0.460 |
Why?
| | Alcohol Drinking | 1 | 2020 | 764 | 0.440 |
Why?
| | Phenobarbital | 2 | 2023 | 19 | 0.410 |
Why?
| | Emergency Medical Services | 1 | 2019 | 521 | 0.400 |
Why?
| | Ovarian Neoplasms | 1 | 2018 | 482 | 0.400 |
Why?
| | Humans | 28 | 2025 | 129527 | 0.390 |
Why?
| | Acetylcysteine | 2 | 2021 | 145 | 0.350 |
Why?
| | Sodium Nitrite | 2 | 2021 | 39 | 0.340 |
Why?
| | Hospitalization | 1 | 2019 | 2076 | 0.320 |
Why?
| | Rivastigmine | 1 | 2024 | 5 | 0.220 |
Why?
| | Adult | 9 | 2025 | 35505 | 0.220 |
Why?
| | Lorazepam | 1 | 2023 | 26 | 0.220 |
Why?
| | Female | 10 | 2025 | 68650 | 0.210 |
Why?
| | Retrospective Studies | 5 | 2024 | 14532 | 0.190 |
Why?
| | Eating | 2 | 2021 | 371 | 0.190 |
Why?
| | Poisons | 1 | 2021 | 20 | 0.180 |
Why?
| | Methemoglobinemia | 1 | 2020 | 13 | 0.170 |
Why?
| | Antidotes | 1 | 2021 | 136 | 0.170 |
Why?
| | Male | 9 | 2025 | 63586 | 0.160 |
Why?
| | Gold Compounds | 1 | 2019 | 5 | 0.160 |
Why?
| | Cyanates | 1 | 2019 | 4 | 0.160 |
Why?
| | Digoxin | 1 | 2019 | 28 | 0.160 |
Why?
| | Fatal Outcome | 1 | 2020 | 300 | 0.160 |
Why?
| | Cardiotoxicity | 1 | 2019 | 33 | 0.160 |
Why?
| | Potassium Cyanide | 1 | 2019 | 18 | 0.160 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2019 | 59 | 0.160 |
Why?
| | Acidosis, Lactic | 1 | 2019 | 46 | 0.150 |
Why?
| | Referral and Consultation | 1 | 2024 | 732 | 0.150 |
Why?
| | Insurance Coverage | 1 | 2020 | 219 | 0.150 |
Why?
| | Administration, Intranasal | 1 | 2019 | 84 | 0.150 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2503 | 0.150 |
Why?
| | Administration, Intravenous | 1 | 2019 | 142 | 0.150 |
Why?
| | Intubation, Intratracheal | 1 | 2021 | 247 | 0.150 |
Why?
| | Gold | 1 | 2019 | 119 | 0.150 |
Why?
| | Respiratory Aspiration | 1 | 2018 | 31 | 0.150 |
Why?
| | Prescription Drug Misuse | 1 | 2018 | 40 | 0.140 |
Why?
| | Vasodilation | 1 | 2021 | 476 | 0.140 |
Why?
| | Methadone | 1 | 2019 | 92 | 0.140 |
Why?
| | Commerce | 1 | 2018 | 68 | 0.140 |
Why?
| | Vomiting | 1 | 2018 | 129 | 0.140 |
Why?
| | Electronic Health Records | 1 | 2025 | 977 | 0.140 |
Why?
| | Plant Extracts | 1 | 2019 | 198 | 0.140 |
Why?
| | Abdominal Pain | 1 | 2018 | 142 | 0.130 |
Why?
| | Respiration, Artificial | 1 | 2021 | 615 | 0.130 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 244 | 0.120 |
Why?
| | Comorbidity | 1 | 2020 | 1548 | 0.120 |
Why?
| | Home Care Services | 1 | 2019 | 244 | 0.120 |
Why?
| | Sex Factors | 1 | 2020 | 1966 | 0.110 |
Why?
| | Chronic Disease | 1 | 2020 | 1722 | 0.110 |
Why?
| | Treatment Outcome | 2 | 2019 | 10232 | 0.110 |
Why?
| | Aged, 80 and over | 3 | 2020 | 7052 | 0.110 |
Why?
| | Age Factors | 1 | 2020 | 3150 | 0.100 |
Why?
| | Suicide | 1 | 2019 | 613 | 0.100 |
Why?
| | Clinical Laboratory Techniques | 1 | 2013 | 94 | 0.090 |
Why?
| | Phenylbutyrates | 1 | 2011 | 22 | 0.090 |
Why?
| | Oncogene Proteins | 1 | 2011 | 54 | 0.090 |
Why?
| | Elbow | 1 | 2011 | 56 | 0.090 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2011 | 123 | 0.080 |
Why?
| | Young Adult | 4 | 2024 | 12438 | 0.080 |
Why?
| | Elbow Joint | 1 | 2011 | 67 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5078 | 0.070 |
Why?
| | Prospective Studies | 1 | 2018 | 7150 | 0.060 |
Why?
| | Middle Aged | 2 | 2025 | 31087 | 0.060 |
Why?
| | Parkinson Disease | 1 | 2011 | 462 | 0.060 |
Why?
| | Infant | 1 | 2019 | 9005 | 0.060 |
Why?
| | Obstetrics and Gynecology Department, Hospital | 1 | 2024 | 9 | 0.060 |
Why?
| | Tertiary Care Centers | 1 | 2024 | 153 | 0.050 |
Why?
| | Primary Health Care | 1 | 2013 | 1677 | 0.050 |
Why?
| | Anxiety Disorders | 1 | 2024 | 357 | 0.040 |
Why?
| | United States | 1 | 2018 | 13865 | 0.040 |
Why?
| | Alanine Transaminase | 1 | 2021 | 154 | 0.040 |
Why?
| | Methemoglobin | 1 | 2020 | 20 | 0.040 |
Why?
| | Poison Control Centers | 1 | 2021 | 88 | 0.040 |
Why?
| | Inpatients | 1 | 2024 | 476 | 0.040 |
Why?
| | Iron | 1 | 2021 | 283 | 0.040 |
Why?
| | Pregnancy Complications | 1 | 2024 | 493 | 0.040 |
Why?
| | Exercise | 1 | 2011 | 1931 | 0.040 |
Why?
| | Plant Roots | 1 | 2019 | 44 | 0.040 |
Why?
| | Patient Care Team | 1 | 2024 | 600 | 0.040 |
Why?
| | Mortality | 1 | 2018 | 306 | 0.030 |
Why?
| | Mental Disorders | 1 | 2024 | 1026 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1261 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2643 | 0.030 |
Why?
| | Weight Loss | 1 | 2019 | 738 | 0.030 |
Why?
| | Adolescent | 3 | 2019 | 20409 | 0.030 |
Why?
| | Liver | 1 | 2021 | 1836 | 0.030 |
Why?
| | Delayed Diagnosis | 1 | 2013 | 79 | 0.020 |
Why?
| | Pregnancy | 1 | 2024 | 6412 | 0.020 |
Why?
| | Medical Errors | 1 | 2013 | 107 | 0.020 |
Why?
| | Protein Deglycase DJ-1 | 1 | 2011 | 11 | 0.020 |
Why?
| | Peroxiredoxins | 1 | 2011 | 24 | 0.020 |
Why?
| | Aged | 2 | 2021 | 22063 | 0.020 |
Why?
| | Torque | 1 | 2011 | 82 | 0.020 |
Why?
| | Evidence-Based Practice | 1 | 2013 | 211 | 0.020 |
Why?
| | Muscular Diseases | 1 | 2011 | 109 | 0.020 |
Why?
| | Quality Indicators, Health Care | 1 | 2013 | 297 | 0.020 |
Why?
| | Neuroprotective Agents | 1 | 2011 | 121 | 0.020 |
Why?
| | Muscle Fatigue | 1 | 2011 | 101 | 0.020 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2011 | 208 | 0.020 |
Why?
| | Patient Participation | 1 | 2013 | 412 | 0.020 |
Why?
| | Isometric Contraction | 1 | 2011 | 187 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2011 | 368 | 0.020 |
Why?
| | Up-Regulation | 1 | 2011 | 832 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2011 | 422 | 0.020 |
Why?
| | Proteins | 1 | 2011 | 944 | 0.010 |
Why?
| | Quality Improvement | 1 | 2013 | 1103 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2011 | 1261 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 10499 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2011 | 4087 | 0.010 |
Why?
| | Neurons | 1 | 2011 | 1509 | 0.010 |
Why?
| | Biomarkers | 1 | 2011 | 3968 | 0.010 |
Why?
| | Child | 1 | 2018 | 20932 | 0.010 |
Why?
| | Mice | 1 | 2011 | 16973 | 0.010 |
Why?
| | Animals | 1 | 2011 | 35334 | 0.000 |
Why?
|
|
Lebin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|